Follow the people · Insider

SP

Sushil Patel

Insider · Chief Executive Officer · REPL

Sushil Patel files insider transactions with the SEC as a chief executive officer of Replimune Group (REPL). We hold 3 disclosed purchases and sales filed since 5 May 2021, 2 of them in the last 90 days.

  • Files forREPL
  • Disclosed buys and sells3 in all, 2 in the last 90 days
  • Last disclosure12 August 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 3 May 202110 August 2026Chief Executive Officer · Replimune Group (REPL)23 Form 4 lines · source: SEC Form 4
  • Filed 16 June 202229 June 2026Director · Revolution Medicines (RVMD)32 Form 4 lines · source: SEC Form 4

Everything they disclosed

55 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.